Dynavax Technologies CorporationDynavax Technologies CorporationDynavax Technologies Corporation

Dynavax Technologies Corporation

No trades
See on Supercharts
Market capitalization
‪1.54 B‬USD
−0.05USD
‪−6.39 M‬USD
‪232.28 M‬USD
‪130.21 M‬
Beta (1Y)
0.31

About Dynavax Technologies Corporation

CEO
Ryan Spencer
Headquarters
Emeryville
Employees (FY)
408
Founded
1996
ISIN
US2681582019
FIGI
BBG000BFX694
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of DVAX is 11.80 USD — it has increased by 4.06% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Dynavax Technologies Corporation stocks are traded under the ticker DVAX.
Dynavax Technologies Corporation is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
DVAX stock is 5.42% volatile and has beta coefficient of 0.31. Check out the list of the most volatile stocks — is Dynavax Technologies Corporation there?
One year price forecast for Dynavax Technologies Corporation has a max estimate of 29.00 USD and a min estimate of 20.00 USD.
DVAX earnings for the last quarter are 0.10 USD per share, whereas the estimation was −0.04 USD resulting in a 364.83% surprise. The estimated earnings for the next quarter are −0.01 USD per share. See more details about Dynavax Technologies Corporation earnings.
Dynavax Technologies Corporation revenue for the last quarter amounts to ‪69.51 M‬ USD despite the estimated figure of ‪60.30 M‬ USD. In the next quarter revenue is expected to reach ‪52.72 M‬ USD.
Yes, you can track Dynavax Technologies Corporation financials in yearly and quarterly reports right on TradingView.
DVAX stock has fallen by 1.75% compared to the previous week, the month change is a 1.42% fall, over the last year Dynavax Technologies Corporation has showed a 9.01% increase.
DVAX net income for the last quarter is ‪219.00 K‬ USD, while the quarter before that showed ‪14.29 M‬ USD of net income which accounts for −98.47% change. Track more Dynavax Technologies Corporation financial stats to get the full picture.
Today Dynavax Technologies Corporation has the market capitalization of ‪1.54 B‬, it has decreased by 2.11% over the last week.
No, DVAX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, DVAX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Dynavax Technologies Corporation stock right from TradingView charts — choose your broker and connect to your account.
DVAX reached its all-time high on Nov 29, 2006 with the price of 106.60 USD, and its all-time low was 1.50 USD and was reached on Nov 20, 2008.
See other stocks reaching their highest and lowest prices.
As of Apr 21, 2024, the company has 408.00 employees. See our rating of the largest employees — is Dynavax Technologies Corporation on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Dynavax Technologies Corporation technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Dynavax Technologies Corporation stock shows the sell signal. See more of Dynavax Technologies Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Dynavax Technologies Corporation future price: according to them, DVAX price has a max estimate of 29.00 USD and a min estimate of 20.00 USD. Read a more detailed Dynavax Technologies Corporation forecast: see what analysts think of Dynavax Technologies Corporation and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Dynavax Technologies Corporation EBITDA is ‪−26.77 M‬ USD, and current EBITDA margin is −11.53%. See more stats in Dynavax Technologies Corporation financial statements.